Skip to main content
SER logo
SER
(NYSEAMERICAN)
Serina Therapeutics, Inc.
$2.12-- (--)
Loading... - Market loading

Serina Therapeutics (SER) Stock Price & Financial Analysis

Serina Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.90 - $2.16
52-Week High$7.92
52-Week Low$1.22
Open$2.11
Volume397.15K
Average Volume (3M)397.15K
Market Cap21.92M
Shares Outstanding10.34M
Price to Sales (P/S)188.95
Price to Book (P/B)12.45
EV/EBITDA-0.88
Revenue (TTM)116.00K
Net Income (TTM)-18.59M
Free Cash Flow (TTM)-16.57M
EPS (TTM)$-1.80
Profit Margin-16022.41%
Operating Margin-20141.38%
Return on Equity (ROE)-1056.02%
Debt to Equity1.73
50-Day MA$2.13
200-Day MA$3.97
52-Week Change-60.30%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Serina Therapeutics

What is the current stock price for SER?

As of the latest trading session, SER stock trades at $2.12. The 52-week range is $1.22–$7.92, with a day range of $1.90–$2.16.

What is the P/E ratio for SER?

The P/E ratio (Price-to-Earnings) for SER is shown in the Key Statistics section. This valuation metric helps compare Serina Therapeutics, Inc. to industry peers.

Does SER pay dividends?

Serina Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SER?

Analyst ratings and recommendations for SER are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of SER?

Serina Therapeutics's market capitalization is $21.9M, classifying it as a micro-cap company. Serina Therapeutics operates in the Healthcare sector within the Biotechnology industry.